These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37334614)

  • 1. Open Bite Malocclusion and Orofacial Dysfunction in Patients with Myotonic Dystrophy Type 1 and Duchenne Muscular Dystrophy.
    Havner C; Roussakis AÖ; Sjögreen L; Westerlund A
    J Neuromuscul Dis; 2023; 10(5):885-896. PubMed ID: 37334614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of myotonic dystrophy and Duchenne muscular dystrophy on the orofacial muscles and dentofacial morphology.
    Kiliaridis S; Katsaros C
    Acta Odontol Scand; 1998 Dec; 56(6):369-74. PubMed ID: 10066119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysphagia in Duchenne muscular dystrophy versus myotonic dystrophy type 1.
    Umemoto G; Furuya H; Kitashima A; Sakai M; Arahata H; Kikuta T
    Muscle Nerve; 2012 Oct; 46(4):490-5. PubMed ID: 22987688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nasal flaring during hypoxemia in myotonic dystrophy and duchenne muscular dystrophy].
    Suzuki M; Oya Y; Murakami Y; Ogawa M; Kawai M
    Rinsho Shinkeigaku; 2009 May; 49(5):278-80. PubMed ID: 19594107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occlusal traits and longitudinal dental changes in children and adolescents with congenital or childhood onset myotonic dystrophy.
    Fontinha C; Engvall M; Sjögreen L; Mårtensson Å; Ekström AB; Kiliaridis S
    Eur J Orthod; 2021 Oct; 43(5):527-533. PubMed ID: 33196085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient engagement in clinical trial design for rare neuromuscular disorders: impact on the DELIVER and ACHIEVE clinical trials.
    Furlong P; Dugar A; White M
    Res Involv Engagem; 2024 Jan; 10(1):1. PubMed ID: 38167117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time dependent changes of variables associated with malocclusion in patients with Duchenne muscular dystrophy.
    Matsumoto S; Morinushi T; Ogura T
    J Clin Pediatr Dent; 2002; 27(1):53-61. PubMed ID: 12413173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orofacial dysfunction in Duchenne muscular dystrophy.
    Botteron S; Verdebout CM; Jeannet PY; Kiliaridis S
    Arch Oral Biol; 2009 Jan; 54(1):26-31. PubMed ID: 18805518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orofacial Manifestations Associated with Muscular Dystrophies: A Review.
    Papaefthymiou P; Kekou K; Özdemir F
    Turk J Orthod; 2022 Mar; 35(1):67-73. PubMed ID: 35370136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporomandibular dysfunction in adult patients with myotonic dystrophy (DM1).
    Mejersjö C; Kiliaridis S
    J Oral Rehabil; 2017 Oct; 44(10):749-755. PubMed ID: 28600825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of myotonic dystrophy type 1 on temporomandibular joint and dentofacial morphology: A CBCT analysis.
    Evlice B; Duyan Yuksel H; Evlice A; Koc F
    J Oral Rehabil; 2023 Oct; 50(10):958-964. PubMed ID: 37294889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growing patients with Duchenne muscular dystrophy: longitudinal changes in their dentofacial morphology and orofacial functional capacities.
    Egli F; Botteron S; Morel C; Kiliaridis S
    Eur J Orthod; 2018 Apr; 40(2):140-148. PubMed ID: 28520860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy.
    Esposito G; Ruggiero R; Savarese M; Savarese G; Tremolaterra MR; Salvatore F; Carsana A
    Clin Chem Lab Med; 2013 Dec; 51(12):2239-45. PubMed ID: 23729582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning disabilities in neuromuscular disorders: a springboard for adult life.
    Astrea G; Battini R; Lenzi S; Frosini S; Bonetti S; Moretti E; Perazza S; Santorelli FM; Pecini C
    Acta Myol; 2016 Oct; 35(2):90-95. PubMed ID: 28344438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK is mitochondrial medicine for neuromuscular disorders.
    Mikhail AI; Ng SY; Mattina SR; Ljubicic V
    Trends Mol Med; 2023 Jul; 29(7):512-529. PubMed ID: 37080889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subjective oral health, malocclusions and oral health related quality of life in patients with Duchenne muscular dystrophy].
    Haverkamp BF; Hollaar VRY; Lagarde MLJ; Knuijt S
    Ned Tijdschr Tandheelkd; 2024 Jan; 131(1):28-33. PubMed ID: 38193355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
    Kalra S; Montanaro F; Denning C
    J Neuromuscul Dis; 2016 Aug; 3(3):309-332. PubMed ID: 27854224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches in the therapy of cardiomyopathy in muscular dystrophy.
    McNally EM
    Annu Rev Med; 2007; 58():75-88. PubMed ID: 17217326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dentofacial characteristics of growing patients with Duchenne muscular dystrophy: a morphological study.
    Morel-Verdebout C; Botteron S; Kiliaridis S
    Eur J Orthod; 2007 Oct; 29(5):500-7. PubMed ID: 17974540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.